• SHOP
    • COMBOS
    • TESTIMONIALS
    • CART
    • INGREDIENTS
      • 2-DEOXY-D-GLUCOSE (2DG)
      • ACACIA CYANOPHYLLA FLOWER
      • ACORI GRAMINEI RHIZOMA
      • AEGLE MARMELOS CORREA
      • AGARICUS BLAZEI
      • AGED GARLIC EXTRACT
      • AFRAMOMUM MELEGUETA
      • ALOE ARBORESCENS
      • ALBIZIA
      • ALPINIA OFFICINARUM
      • ALTERNANTHERA SESSILIS
      • AMERICAN GINSENG
      • AMYGDALIN
      • ANACYCLUS PYRETHRUM
      • ANGELICA ARCHANGELICA
      • ANGELICA SINENSIS
      • ANTRODIA
      • APIGENIN
      • ARTICHOKE LEAF
      • ARTOCARPIN
      • AJUGA TURKESTANICA
      • ASHWAGANDHA
      • ASPALATHIN
      • ASTRAGALUS COMPLANATUS
      • AVENA SATIVA
      • BACOPA MONNIERI
      • BAVACHIN
      • BEE POLLEN
      • BETULINIC ACID
      • BOSWELLIC ACID
      • BREVILIN A
      • CAMPESTEROL
      • CAPSAICIN
      • CARCININE
      • CASTICIN
      • CHRYSIN
      • CIANIDANOL
      • CINNAMOMUM ZEYLANICUM
      • CITRULLUS COLOCYNTHIS
      • CITRUS RETICULATA PEEL
      • CODONOPSIS
      • CONJUGATED LINOLEIC ACID
      • COSTUNOLIDE
      • CYANIDIN
      • CUCURBITACIN D
      • DAIDZEIN
      • DECURSIN
      • DELPHINIDIN
      • DIGITALIS PURPREA (DIGOXIN)
      • DIOSMIN
      • ELLAGIC ACID
      • EMBELIN
      • ERIODICTYOL
      • GALLIC ACID
      • GLYCITEIN
      • GLYCYRRHIZIN
      • HYPERFORIN
      • ICARIIN
      • ISORHAMNETIN
      • ISOORIENTIN
      • ISOVITEXIN
      • JACEOSIDIN
      • KAEMPFEROL
      • KIGELIA AFRICANA
      • KURARINONE
      • LEMON BALM
      • LICORICIDIN
      • LIPOIC ACID
      • LUPEOL
      • MAGNOLOL
      • MULBERRY LEAF
      • NARINGENIN
      • NOBILETIN
      • OLEACEIN
      • OLEANOLIC ACID
      • OLIVE OIL
      • ORIDONIN
      • PARTHENOLIDE
      • PHLOROGLUCINOL
      • PHLORIZIN
      • PICEATANNOL
      • PRISTIMERIN
      • PROANTHOCYANIDINS
      • PROCYANIDIN B3
      • PSEUDOLARIC ACID B
      • PTEROSTILBENE
      • RUTIN
      • SOLIDAGO VIRGAUREA
      • TANGERETIN
      • TARAXASTEROL
      • TRICHOSTATIN A
      • WEDELOLACTONE
      • WOGONIN
      • YERBA MATE
    • ABOUT
    • SCIENTIFIC STUDIES
      • ADAPTOGENS
      • ADIPOCYTE APOPTOSIS (KILLING FAT CELLS)
      • ADDICTION AND THE BRAIN
      • ADDICTION & STRESS
      • ADDICTION WITHDRAWAL
      • ADIPOCYTE DEDIFFERENTIATION (THE REVERSAL OF FAT FORMATION)
      • ADIPOCYTE DIFFERENTIATION
      • ALLERGIES & CYTOKINES
      • ALDOSTERONE & OBESITY/HYPERTENSION
      • ALZHEIMER’S, DEMENTIA, PARKINSON’S
      • ANTI-ACNE EFFECT OF FLAVONOIDS AND POLYPHENOLS
      • ADVANCED GLYCATION END PRODUCTS (AGES)
      • ADDICTION TREATMENT
      • AMPK
      • ANTI AGING
      • ANTIAGING EFFECTS OF COFFEE
      • ANTI-AGING EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-APOPTOTIC PATHWAYS
      • ANTI ATHEROGENIC
      • ANTI-CANCER EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI CARIOGENIC (Protecting From Tooth Decay)
      • ANTI COVID-19 EFFECTS OF MEDICINAL PLANTS, FLAVONOIDS & POLYPHENOLS
      • ANTI GLYCATIVE
      • ANTI GLYCATION AGENTS
      • ANTI-INFLAMMATORY EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-VIRAL EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI WRINKLE AGENTS
      • APOPTOSIS
      • APOPTOSIS IN 3T3-L1
      • AUTOPHAGY
      • BCL-2
      • BCL-W
      • BCL-XL
      • BDNF
      • BECLIN-1 & AUTOPHAGY
      • BH3 MIMETICS
      • BIM aka BCL2L11
      • BMI-1
      • BRASSINOSTEROIDS
      • CALORIE RESTRICTION
      • CALORIE RESTRICTION & LIFESPAN EXTENSION
      • CARBAMYLATION
      • CARBONYL SCAVENGER
      • CARBONYL STRESS
      • CARDIOPROTECTIVE AGENTS
      • CARDIAC GLYCOSIDES
      • CATALASE
      • CELL CYCLE ARREST
      • CENTENARIANS
      • CHOLESTEROL EFFLUX
      • COGNITIVE ENHANCEMENT
      • COLD SHOCK PROTEINS
      • COLD-INDUCIBLE RNA-BINDING PROTEIN (CIRBP) & DNA REPAIR
      • CONDITIONED PLACE PREFERENCE
      • CORTICOTROPIN RELEASING FACTOR
      • CRYOTHERAPY
      • CRYOLIPOLYSIS: FREEZING FAT TO DEATH
      • CYP2E1
      • CYTOKINES IN PAIN, INFLAMMATION & AGING
      • DAF-16
      • DIABETES & CANCER
      • DIHYDROTESTOSTERONE (DHT)
      • DNA METHYLATION & AGING
      • DNA REPAIR
      • DNA REPAIR VIA FLAVONOIDS & POLYPHENOLS
      • ADDICTION & DOPAMINE
      • DRY FASTING AND FLUID RESTRICTION FASTING
      • DYNORPHIN
      • ELLAGITANNINS
      • ENLARGED HEART AND CARDIOMEGALY
      • EPIGENETIC MODIFIERS
      • EPINEPHRINE
      • ERGOGENIC AGENTS (INCREASE ATHLETIC PERFORMANCE)
      • EXCITOXICITY & THE BRAIN
      • EXTRACELLULAR MATRIX STIFFENING (10TH HALLMARK OF AGING)
      • EXTENDS LIFESPAN
      • EXTINCTION TRAINING
      • FASTING BRAIN
      • FASTING CANCER
      • FASTING & CANCER
      • FASTING MIMICKING DIET
      • FEAR EXTINCTION
      • FGF21
      • FLAVONES
      • GABA (γ-AMINOBUTYRIC ACID)
      • GALLOTANNINS
      • GLUCONEOGENESIS
      • GLUTAMATE & BRAIN
      • GLYCATION
      • KLOTHO
      • FASTING, CALORIE RESTRICTION & EXTENDING LIFESPAN
      • FOXO3
      • FOXO4
      • HALLMARKS OF AGING
      • HEPATOPROTECTIVE AGENTS (KEEPING LIVER HEALTHY)
      • HMGB1
      • HORMESIS
      • HPA AXIS
      • HSP70, THE ANTI-AGING PROTEIN
      • HSP90 INHIBITORS
      • HYPERGLYCEMIA
      • HYPERINSULINEMIA
      • HYPOACTIVE SEXUAL DESIRE (WHY PEOPLE HAVE ZERO SEX DRIVE)
      • HYPOCRETIN OREXIN
      • IKK
      • IL-6/STAT3
      • IRISIN
      • ISOFLAVONES
      • IMMUNOSENESCENCE
      • INCREASE PROTEIN SYNTHESIS
      • INFECTOBESITY
      • INFLAMMATION & ANXIETY
      • INFLAMMATION & CANCER
      • INFLAMMATION & DEPRESSION
      • INFLAMMATION & OBESITY
      • INFLAMMAGING
      • INHIBITION OF RENAL GLUCOSE REABSORPTION
      • INSULIN & AGING
      • INSULIN & CANCER: HOW INSULIN LITERALLY PROTECTS CANCER CELLS FROM BEING KILLED
      • INSULIN & MTOR
      • INSULIN & OBESITY
      • INTERMITTENT FASTING
      • JAK INHIBITION ALLEVIATES SASP
      • JNK ACTIVATION PREVENTS PREMATURE SENESCENCE
      • KETONE BODIES
      • KETOGENIC DIET
      • LEYDIG CELL STEROIDOGENESIS
      • LIFESPAN EXTENSION
      • LIPOLYTIC AGENTS
      • LIPID DROPLETS
      • LIPOLYSIS (THE DECOMPOSITION OF BODY FAT)
      • LOWERING CHOLESTEROL THRU FASTING, DIET & MEDICINAL PLANTS
      • MATRIX METALLOPROTEINASES (MMPs)
      • MCL-1
      • MDM2 INHIBITION AS SASP INHIBITOR
      • MEDITERRANEAN DIET
      • MENAQUINONE 4
      • METABOLIC REPROGRAMMING
      • METABOLIC SYNDROME EXTRACT
      • METHIONINE RESTRICTION
      • MITOCHONDRIAL UNCOUPLING
      • MONKEYPOX
      • MSG (MONOSOSODIUM GLUTAMATE)
      • MUSCLE FORCE PRODUCTION
      • MUSCLE ATROPHY (PREVENTING)
      • MYOGENESIS
      • MYOSTATIN INHIBITION
      • MYOSTATIN INHIBITION PRESERVES MUSCLE
      • mTORC2
      • mTOR: THE RAPID AGING PATHWAY
      • NATURAL ANTICOAGULANTS
      • NATURAL AROMATASE INHIBITORS
      • NEUROGENESIS (GROWING NEW BRAIN CELLS)
      • NEUROCHEMISTRY OF ADDICTION
      • NEUROPLASTICITY
      • NEUROINFLAMMATION
      • NEUROPROTECTIVE AGENTS
      • NMDA & ANXIETY & DEPRESSION
      • NMDA RECEPTOR AND FEAR
      • NON-OPIOID ANALGESICS (PLANT BASED)
      • NOOTROPICS
      • NORADRENERGIC
      • NOREPINEPHRINE
      • NRF2: MASTER REGULATOR OF THE AGING PROCESS
      • NF-KB
      • ONCOGENE ACTIVATION INDUCED SENESCENCE
      • OVERNUTRITION
      • OXIDATIVE STRESS & AGING
      • P16INK4A
      • P38MAPK
      • P53: TUMOR SUPRESSOR
      • PERIODONTITIS
      • PHYTOCHEMICALS
      • PHYTOSTEROLS
      • PHYTOSTANOLS
      • PHYTOECDYSTEROIDS
      • PROANTHOCYANIDINS
      • PROTEIN CARBONYLATION
      • POLYAMINES & THEIR EFFECT ON BRAIN (NMDA, DEPRESSION, SUICIDE RISK)
      • PPARY2
      • PREMATURE SENESCENCE
      • PREVENTING SKIN AGING
      • PUFAS
      • PURGATIVES
      • RAPAMYCIN (MTOR INHIBITION)
      • RECEPTOR “Κ OPIOID”
      • RED WINE
      • RENAL (KIDNEY) PROTECTIVE AGENTS
      • REMINERALIZATION OF TEETH
      • REPAIR OF DNA BREAKS “DOUBLE STRAND”
      • RESTORE INSULIN SENSITIVITY
      • SASP & ADIPOSE TISSUE
      • SENESCENT CELLS, SASP & SENOLYTICS
      • SENESCENCE-BETA-GALACTOSIDASE (SA-β-gal or SABG)
      • SGLT2 INHIBITORS
      • SGLT2 INHIBITION FOR LIFESPAN EXTENSION
      • SHBG
      • SIRT1
      • SKELETAL MUSCLE HYPERTROPHY (THE SCIENCE OF BUILDING MUSCLE)
      • SKIN ELASTICITY
      • SKIN PHOTOAGING (Preventing & Repairing)
      • SLEEP DEPRIVATION AS THERAPY FOR DEPRESSION
      • SIRT1 & LONGEVITY
      • SMALLPOX
      • SUGAR & AGING
      • STAR PROTEIN
      • STAT3
      • STEM CELL EXHAUSTION
      • STEM CELL REGENERATION
      • STEM CELL THERAPY
      • STIMULATED LIPOLYSYS
      • STEROIDOGENESIS (THE PRODUCTION OF HORMONES IN BODY)
      • STREPTOCOCCUS MUTANS (MAIN BACTERIA BEHIND TOOTH DECAY)
      • STRESS & AGING
      • STRESS & THE BRAIN
      • TELOMERE SHORTENING & PREMATURE AGING
      • TIME RESTRICTED FEEDING
      • TRAUMATIC BRAIN INJURY (HEALING)
      • TRYPTOPHAN HYDROXYLASE 2
      • VISCERAL ADIPOSITY
    • HOME
    • CONTACT
    • INTERSTELLAR 88/8: EXTREME WEIGHTLOSS PROTOCOL
    • The Ultimate Dry Fasting Resource
    0
    TIME RESTRICTED FEEDING
    December 21, 2021
    CATALASE
    December 22, 2021
    1. Stress, CORTICOTROPIN –RELEASING FACTOR , and behavior
    2. Chemical and biological characterization of CORTICOTROPIN RELEASING FACTOR
    3. Psychiatric implications of basic and clinical studies with CORTICOTROPIN –RELEASING FACTOR
    4. CORTICOTROPIN –RELEASING FACTOR has an anxiogenic action in the social interaction test
    5. Effects of CORTICOTROPIN –RELEASING FACTOR and growth hormone-RELEASING FACTOR on sleep and activity in rats
    6. Influence of CORTICOTROPIN –RELEASING FACTOR on reproductive functions in the rat
    7. Behavioral effects of CORTICOTROPIN –RELEASING FACTOR : localization and characterization of central effects
    8. Isolation and sequence analysis of the human CORTICOTROPIN ‐RELEASING FACTOR precursor gene.
    9. CORTICOTROPIN –RELEASING FACTOR : actions on the sympathetic nervous system and metabolism
    10. Stress-induced inhibition of reproductive functions: role of endogenous CORTICOTROPIN –RELEASING FACTOR
    11. Characterization of rat hypothalamic CORTICOTROPIN –RELEASING FACTOR
    12. Primary structure of CORTICOTROPIN –RELEASING FACTOR from ovine hypothalamus
    13. CORTICOTROPIN RELEASING FACTOR decreases postburst hyperpolarizations and excites hippocampal neurons
    14. Interleukin-1 stimulates the secretion of hypothalamic CORTICOTROPIN –RELEASING FACTOR
    15. CORTICOTROPIN RELEASING FACTOR produces behavioural activation in rats
    16. CORTICOTROPIN –RELEASING FACTOR -producing neurons in the rat activated by interleukin-1
    17. Elevated concentrations of CSF CORTICOTROPIN –RELEASING FACTOR -like immunoreactivity in depressed patients
    18. Intraventricular CORTICOTROPIN –RELEASING FACTOR enhances behavioral effects of novelty
    19. CORTICOTROPIN –RELEASING FACTOR receptors are widely distributed within the rat central nervous system: an autoradiographic study
    20. The role of CORTICOTROPIN –RELEASING FACTOR in the pathogenesis of major depression
    21. Immunocytochemical localization of CORTICOTROPIN ‐RELEASING FACTOR (CRF) in the rat brain
    22. In vivo CORTICOTROPIN –RELEASING FACTOR -induced secretion of adrenoCORTICOTROPIN , β-endorphin, and corticosterone
    23. Mediation by CORTICOTROPIN RELEASING FACTOR (CRF) of adenohypophysial hormone secretion
    24. [38] Assay of CORTICOTROPIN RELEASING FACTOR
    25. CORTICOTROPIN –RELEASING FACTOR immunoreactivity is widely distributed within the central nervous system of the rat: an immunohistochemical study
    26. CORTICOTROPIN –RELEASING FACTOR : effects on the autonomic nervous system and visceral systems.
    27. Hypothalamic control of adrenoCORTICOTROPIN secretion: advances since the discovery of 41-residue CORTICOTROPIN –RELEASING FACTOR
    28. Mechanisms of action of CORTICOTROPIN –RELEASING FACTOR and other regulators of CORTICOTROPIN release in rat pituitary cells.
    29. CORTICOTROPIN –RELEASING FACTOR receptors in the rat central nervous system: characterization and regional distribution
    30. CSF CORTICOTROPIN –RELEASING FACTOR -like immunoreactivity in depression and schizophrenia.
    31. CORTICOTROPIN –RELEASING FACTOR directly mediates colonic responses to stress
    32. Catecholaminergic modulation of CORTICOTROPIN –RELEASING FACTOR and adrenoCORTICOTROPIN secretion
    33. Reduced CORTICOTROPIN RELEASING FACTOR binding sites in the frontal cortex of suicide victims
    34. Distribution of CORTICOTROPIN –RELEASING FACTOR in rat brain.
    35. Organization of ovine CORTICOTROPIN –RELEASING FACTOR immunoreactive cells and fibers in the rat brain: an immunohistochemical study
    36. Clinical applications of CORTICOTROPIN –RELEASING FACTOR
    37. Interaction of CORTICOTROPIN –RELEASING FACTOR and Arginine Vasopressin on AdrenoCORTICOTROPIN Secretion in Vivo
    38. Physiological and behavioral responses to CORTICOTROPIN –RELEASING FACTOR administration: is CRF a mediator of anxiety or stress responses?
    39. CORTICOTROPIN –RELEASING FACTOR : effects on the sympathetic nervous system and oxygen consumption
    40. Synthetic competitive antagonists of CORTICOTROPIN –RELEASING FACTOR : effect on ACTH secretion in the rat
    41. CORTICOTROPIN –RELEASING FACTOR as the mediator of stress responses
    42. The CORTICOTROPIN –RELEASING FACTOR stimulation test: an aid in the evaluation of patients with Cushing’s syndrome
    43. CORTICOTROPIN –RELEASING FACTOR potentiates acoustic startle in rats: blockade by chlordiazepoxide
    44. Effects of CORTICOTROPIN RELEASING FACTOR on locomotor activity in hypophysectomized rats
    45. CORTICOTROPIN –RELEASING FACTOR activates noradrenergic neurons of the locus coeruleus
    46. Distribution and efferent projections of CORTICOTROPIN –RELEASING FACTOR -like immunoreactivity in the rat amygdaloid complex
    47. CORTICOTROPIN RELEASING FACTOR produces increases in brain excitability and convulsive seizures in rats
    48. Potentiation by vasopressin of CORTICOTROPIN release induced by CORTICOTROPIN –RELEASING FACTOR
    49. Alterations in CORTICOTROPIN –RELEASING FACTOR -like immunoreactivity in discrete rat brain regions after acute and chronic stress
    50. Co-expression of CORTICOTROPIN –RELEASING FACTOR and vasopressin immunoreactivity in parvocellular neurosecretory neurons of the adrenalectomized rat
    51. Chlordiazepoxide attenuates response suppression induced by CORTICOTROPIN –RELEASING FACTOR in the conflict test
    52. CORTICOTROPIN –RELEASING FACTOR modulates defensive-withdrawal and exploratory behavior in rats.
    53. Central nervous system effects of CORTICOTROPIN –RELEASING FACTOR on gastrointestinal transit in the rat
    54. CORTICOTROPIN –RELEASING FACTOR decreases plasma luteinizing hormone levels in female rats by inhibiting gonadotropin-RELEASING hormone release into hypophysial …
    55. Localization, colocalization, and plasticity of CORTICOTROPIN –RELEASING FACTOR immunoreactivity in rat brain.
    56. Anorexia induced by interleukin 1: involvement of CORTICOTROPIN –RELEASING FACTOR
    57. Effect of ethanol on the hypothalamic-pituitary-adrenal axis in the rat: role of CORTICOTROPIN –RELEASING FACTOR (CRF).
    58. CORTICOTROPIN RELEASING FACTOR (CRF)-like immunoreactivity in the rat central nervous system. Extrahypothalamic distribution
    59. Modulation of stress-induced ACTH release by CORTICOTROPIN –RELEASING FACTOR , catecholamines and vasopressin
    60. CORTICOTROPIN RELEASING FACTOR induction of leukocyte-derived immunoreactive ACTH and endorphins
    61. CORTICOTROPIN –RELEASING FACTOR : evidence for a neurotransmitter role in the locus ceruleus during hemodynamic stress
    62. CORTICOTROPIN –RELEASING FACTOR
    63. CORTICOTROPIN RELEASING FACTOR (CRF): immunoreactive neurones and fibers in rat hypothalamus
    64. Chronic administration of CORTICOTROPIN –RELEASING FACTOR increases pituitary corticotroph number
    65. Evidence for local stimulation of ACTH secretion by CORTICOTROPIN –RELEASING FACTOR in human placenta
    66. Comparison of the biologic actions of CORTICOTROPIN –RELEASING FACTOR and sauvagine
    67. CORTICOTROPIN –RELEASING FACTOR and gonadotropin-RELEASING hormone pulse generator activity in the rhesus monkey
    68. Distribution and characterization of immunoreactive CORTICOTROPIN –RELEASING FACTOR in human tissues
    69. Inhibition of adrenocorticotropic hormone secretion in the rat by immunoneutralization of CORTICOTROPIN –RELEASING FACTOR
    70. Stimulation of hypothalamic β-endorphin and dynorphin release by CORTICOTROPIN –RELEASING FACTOR (in vitro)
    71. CORTICOTROPIN –RELEASING FACTOR produces fear-enhancing and behavioral activating effects following infusion into the locus coeruleus
    72. Stress-induced gastrointestinal secretory and motor responses in rats are mediated by endogenous CORTICOTROPIN –RELEASING FACTOR
    73. Central nervous system action of CORTICOTROPIN –RELEASING FACTOR to inhibit gastric emptying in rats
    74. CORTICOTROPIN –RELEASING FACTOR -like activity in human placental extracts
    75. Presence op CORTICOTROPIN RELEASING FACTOR -like immunoreactivity in hypophysial portal blood
    76. CORTICOTROPIN –RELEASING FACTOR is a potent inhibitor of sexual receptivity in the female rat
    77. Ectopic secretion of CORTICOTROPIN –RELEASING FACTOR as a cause of Cushing’s syndrome: a clinical, morphologic, and biochemical study
    78. The distribution of CORTICOTROPIN RELEASING FACTOR -like immunoreactive neurons in rat brain
    79. Effects of CORTICOTROPIN –RELEASING FACTOR on food intake and brown adipose tissue thermogenesis in rats
    80. CORTICOTROPIN RELEASING FACTOR ‐like immunoreactivity in the rat brain as revealed by a modified cobalt‐glucose oxidase‐diaminobenzidine method
    81. CORTICOTROPIN –RELEASING FACTOR : endocrine and autonomic integration of responses to stress
    82. GnRH release from the mediobasal hypothalamus: in vitro inhibition by CORTICOTROPIN –RELEASING FACTOR
    83. Interleukin-1 stimulates ACTH release by an indirect action which requires endogenous CORTICOTROPIN RELEASING FACTOR
    84. Distribution of CORTICOTROPIN –RELEASING FACTOR receptors in primate brain
    85. CORTICOTROPIN RELEASING FACTOR (CRF) receptor antagonist blocks activating and ‘anxiogenic’actions of CRF in the rat
    86. Involvement of CORTICOTROPIN –RELEASING FACTOR in the anorexia induced by exercise
    87. Stimulant and anxiogenic effects of CORTICOTROPIN RELEASING FACTOR .
    88. CORTICOTROPIN –RELEASING FACTOR antagonist blocks stress-induced fighting in rats
    89. Studies of the nature of the interaction between vasopressin and CORTICOTROPIN –RELEASING FACTOR on adrenoCORTICOTROPIN release in the rat
    90. Immunoreactive CORTICOTROPIN –RELEASING FACTOR in human plasma.
    91. CORTICOTROPIN –RELEASING FACTOR receptors and pituitary adrenal responses during immobilization stress
    92. Cloning and sequence analysis of cDNA for rat CORTICOTROPIN ‐RELEASING FACTOR precursor
    93. CORTICOTROPIN –RELEASING FACTOR receptors in rat forebrain: autoradiographic identification
    94. CORTICOTROPIN –RELEASING FACTOR : a physiologic regulator of adrenal epinephrine secretion
    95. Effects of synthetic ovine CORTICOTROPIN –RELEASING FACTOR , glucocorticoids, catecholamines, neurohypophysial peptides, and other substances on cultured corticotropic …
    96. CORTICOTROPIN –RELEASING FACTOR (CRF): central effects on mean arterial pressure and heart rate in rats.
    97. Arginine vasopressin potentiates adrenoCORTICOTROPIN release induced by ovine CORTICOTROPIN –RELEASING FACTOR .
    98. Interleukin-1 stimulates CORTICOTROPIN –RELEASING FACTOR gene expression in rat hypothalamus
    99. Co-localization of CORTICOTROPIN –RELEASING FACTOR and vasopressin in median eminence neurosecretory vesicles
    100. Neurochemical and behavioral effects of CORTICOTROPIN –RELEASING FACTOR in the ventral tegmental area of the rat.
    101. Studies of the secretion of CORTICOTROPIN –RELEASING FACTOR and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep
    102. Neurotransmitters and peptides modulate the release of immunoreactive CORTICOTROPIN –RELEASING FACTOR from cultured human placental cells
    103. Cocaine stimulates adrenoCORTICOTROPIN (ACTH) secretion through a CORTICOTROPIN –RELEASING FACTOR (CRF)-mediated mechanism
    104. Central and peripheral distribution of CORTICOTROPIN –RELEASING FACTOR .
    105. CORTICOTROPIN –RELEASING FACTOR administered intraventricularly to rhesus monkeys
    106. Effect of centrally administered CORTICOTROPIN RELEASING FACTOR (CRF) on multiple feeding paradigms
    107. Effect of synthetic ovine CORTICOTROPIN –RELEASING FACTOR . Dose response of plasma adrenoCORTICOTROPIN and cortisol.
    108. The Effects of CORTICOTROPIN –RELEASING FACTOR on AdrenoCORTICOTROPIN Secretion from Perifused Pituitaries in vitro: Rapid Inhibition by Glucocorticoids
    109. CORTICOTROPIN RELEASING FACTOR : central nervous system sites of action
    110. CORTICOTROPIN –RELEASING FACTOR (ovine) and vasopressin exert a synergistic effect on adrenoCORTICOTROPIN release in man
    111. The role of pituitary beta-endorphin in mediating CORTICOTROPIN –RELEASING FACTOR -induced antinociception
    112. CORTICOTROPIN –RELEASING FACTOR administration elicits a stress-like activation of cerebral catecholaminergic systems
    113. Central nervous system effects of CORTICOTROPIN RELEASING FACTOR in the dog
    114. Properties and regulation of high-affinity pituitary receptors for CORTICOTROPIN –RELEASING FACTOR
    115. Co-localization of CORTICOTROPIN RELEASING FACTOR and vasopressin mRNA in neurones after adrenalectomy
    116. Electrophysiological actions of CORTICOTROPIN –RELEASING FACTOR in the central nervous system.
    117. Human CORTICOTROPIN –RELEASING FACTOR in man: pharmacokinetic properties and dose-response of plasma adrenoCORTICOTROPIN and cortisol secretion
    118. Distribution of CORTICOTROPIN –RELEASING FACTOR -like immunoreactivity in human brain
    119. Gastrointestinal motor effects of CORTICOTROPIN –RELEASING FACTOR in mice
    120. CORTICOTROPIN –RELEASING FACTOR disrupts sensory responses of brain noradrenergic neurons
    121. A comparison of the effects of CORTICOTROPIN RELEASING FACTOR and sauvagine on food intake
    122. Neurotransmitter modulation of CORTICOTROPIN RELEASING FACTOR secretion into the hypophysial-portal circulation
    123. A CORTICOTROPIN –RELEASING FACTOR antagonist reverses the stress-induced changes of exploratory behavior in mice
    124. CORTICOTROPIN –RELEASING FACTOR (CRF): mechanism to elevate mean arterial pressure and heart rate
    125. Facilitation of immunoreactive CORTICOTROPIN –RELEASING FACTOR secretion into the hypophysial-portal circulation after activation of catecholaminergic pathways or central …
    126. Evidence for differential regulation of CORTICOTROPIN –RELEASING FACTOR and vasopressin immunoreactivities in parvocellular neurosecretory and autonomic-related …
    127. CORTICOTROPIN RELEASING FACTOR : immunocytochemical localization in rat brain
    128. Quantitative in situ hybridization histochemistry reveals increased levels of CORTICOTROPIN –RELEASING FACTOR mRNA after adrenalectomy in rats
    129. Immunoreactive CORTICOTROPIN –RELEASING FACTOR is present in human maternal plasma during the third trimester of pregnancy
    130. Intra-amygdala injections of CORTICOTROPIN RELEASING FACTOR facilitate inhibitory avoidance learning and reduce exploratory behavior in rats
    131. Effects of CORTICOTROPIN –RELEASING FACTOR , neurohypophyseal peptides, and catecholamines on pituitary function.
    132. Cloning and sequence analysis of cDNA for ovine CORTICOTROPIN –RELEASING FACTOR precursor
    133. CORTICOTROPIN –RELEASING FACTOR : pharmacokinetics in man
    134. CORTICOTROPIN –RELEASING FACTOR
    135. CORTICOTROPIN –RELEASING FACTOR attenuates interleukin 1-induced sleep and fever in rabbits
    136. Synaptic interaction of serotonergic axons and CORTICOTROPIN RELEASING FACTOR (CRF) synthesizing neurons in the hypothalamic paraventricular nucleus of the rat
    137. Inhibition of gastric acid secretion in rats by intracerebral injection of CORTICOTROPIN –RELEASING FACTOR
    138. CORTICOTROPIN –RELEASING FACTOR -immunoreactive neurons of the paraventricular nucleus become vasopressin positive after adrenalectomy
    139. CORTICOTROPIN –RELEASING FACTOR (CRF) inhibits gonadotropin-RELEASING hormone (GnRH) release from superfused rat hypothalami in vitro
    140. Evidence for CORTICOTROPIN ‐RELEASING FACTOR , neurotensin, and somatostatin in the neural pathway from the central nucleus of the amygdala to the parabrachial nucleus
    141. Effects of CORTICOTROPIN –RELEASING FACTOR on energy balance in rats are sex dependent
    142. CORTICOTROPIN ‐RELEASING FACTOR receptors: Distribution and regulation in brain, pituitary, and peripheral tissues
    143. Reciprocal changes in CORTICOTROPIN –RELEASING FACTOR (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer’s disease
    144. Dexamethasone inhibits CORTICOTROPIN –RELEASING FACTOR gene expression in the rat paraventricular nucleus
    145. … of lordosis behaviour in the female rat by CORTICOTROPIN –RELEASING FACTOR , β-endorphin/CORTICOTROPIN and luteinizing hormone-RELEASING hormone neuronal systems in the …
    146. CORTICOTROPIN –RELEASING FACTOR Stimulation of AdrenoCORTICOTROPIN and β-Endorphin Release: Effects of Acute and Chronic Stress
    147. Activating and ‘anxiogenic’effects of CORTICOTROPIN RELEASING FACTOR are not inhibited by blockade of the pituitary-adrenal system with dexamethasone
    148. Differential behavioral actions of CORTICOTROPIN –RELEASING FACTOR (CRF)
    149. The effects of intracerebroventricularly injected CORTICOTROPIN –RELEASING FACTOR (CRF) on the central nervous system: behavioural and biochemical studies
    150. Anatomy of the CORTICOTROPIN –RELEASING FACTOR and opiomelanocortin systems of the brain.
    151. CORTICOTROPIN –RELEASING FACTOR (CRF) produces analgesia in humans and rats
    152. CORTICOTROPIN –RELEASING FACTOR regulates proopiomelanocortin messenger ribonucleic acid levels in vivo
    153. Influence of steroids on the hypothalamic CORTICOTROPIN –RELEASING FACTOR and preproenkephalin mRNA responses to stress
    154. PITUITARY MICROADENOMAS CAUSING CUSHING/S DISEASE RESPOND TO CORTICOTROPIN –RELEASING FACTOR
    155. CORTICOTROPIN –RELEASING FACTOR stimulates accumulation of adenosine 3′, 5′-monophosphate in rat pituitary corticotrophs
    156. Immunocytochemical localization of CORTICOTROPIN RELEASING FACTOR (CRF) in the rat spinal cord
    157. CORTICOTROPIN –RELEASING FACTOR in the adrenal medulla.
    158. CORTICOTROPIN –RELEASING FACTOR (CRF)—a review
    159. CORTICOTROPIN RELEASING FACTOR (CRF) has a peripheral site of action for antinociception
    160. Potentiation of acoustic startle by CORTICOTROPIN –RELEASING FACTOR (CRF) and by fear are both reversed by! a-helical CRF (9-41).
    161. CORTICOTROPIN –RELEASING FACTOR receptors and actions in rat Leydig cells
    162. Opioid inhibition of immunoreactive CORTICOTROPIN –RELEASING FACTOR secretion into the hypophysial-portal circulation of rats
    163. Heterogeneity of chandelier neurons in monkey neocortex: CORTICOTROPIN ‐RELEASING FACTOR ‐and parvalbumin‐immunoreactive populations
    164. Adrenergic innervation of CORTICOTROPIN RELEASING FACTOR (CRF)—synthesizing neurons in the hypothalamic paraventricular nucleus of the rat
    165. Propranolol antagonizes the enhanced conditioned fear produced by CORTICOTROPIN RELEASING FACTOR .
    166. Thyrotropic activity of the ovine CORTICOTROPIN –RELEASING FACTOR in the chick embryo
    167. Vasopressin coexists in half of the CORTICOTROPIN –RELEASING FACTOR axons present in the external zone of the median eminence in normal rats
    168. CORTICOTROPIN –RELEASING FACTOR : co-expression within distinct subsets of oxytocin-, vasopressin-, and neurotensin-immunoreactive neurons in the hypothalamus of the …
    169. Effects of purified hypothalamic CORTICOTROPIN –RELEASING FACTOR and other substances on the secretion of adrenoCORTICOTROPIN and β-endorphin-like immunoactivities in …
    170. Regulation of the messenger ribonucleic acid for CORTICOTROPIN –RELEASING FACTOR in the paraventricular nucleus and other brain sites of the rat
    171. NEUROTRANSMITTER REGULATION OF CORTICOTROPIN ‐RELEASING FACTOR IN VITRO
    172. CORTICOTROPIN –RELEASING FACTOR inhibits thermal injury.
    173. Effect of the serotonin reuptake inhibitor fluoxetine on CORTICOTROPIN –RELEASING FACTOR and vasopressin secretion into hypophysial portal blood
    174. CORTICOTROPIN –RELEASING FACTOR is produced by rat Leydig cells and has a major local antireproductive role in the testis
    175. Neuropeptide-Y and ACTH-immunoreactive innervation of CORTICOTROPIN RELEASING FACTOR (CRF)-synthesizing neurons in the hypothalamus of the rat
    176. Immunoreactive CORTICOTROPIN and CORTICOTROPIN RELEASING FACTOR in human hypothalamus, adrenal, lung cancer, and pheochromocytoma
    177. Sympathetic nervous system mediates central CORTICOTROPIN –RELEASING FACTOR induced suppression of natural killer cytotoxicity.
    178. Inhibitory influence of CORTICOTROPIN RELEASING FACTOR on components of sexual behaviour in the male rat
    179. Stimulation of cyclic AMP accumulation and CORTICOTROPIN release by synthetic ovine CORTICOTROPIN –RELEASING FACTOR in rat anterior pituitary cells: site of glucocorticoid …
    180. CORTICOTROPIN RELEASING FACTOR receptor-mediated stimulation of adenylate cyclase activity in the rat brain
    181. Augmentation of acth-RELEASING activity op synthetic CORTICOTROPIN RELEASING FACTOR (crf) by vasopressin in women
    182. CORTICOTROPIN RELEASING FACTOR : basic studies and clinical applications
    183. Continuous administration of synthetic ovine CORTICOTROPIN –RELEASING FACTOR in man. Physiological and pathophysiological implications.
    184. Acute effects of alprazolam and adinazolam on the concentrations of CORTICOTROPIN ‐RELEASING FACTOR in the rat brain
    185. Central administration of CORTICOTROPIN –RELEASING FACTOR modulates oxytocin secretion in the rat
    186. Functional CORTICOTROPIN RELEASING FACTOR receptors in the primate peripheral sympathetic nervous system
    187. CORTICOTROPIN –RELEASING FACTOR as a transmitter in the human olivocerebellar pathway
    188. Cushing’s syndrome due to ectopic production of CORTICOTROPIN –RELEASING FACTOR
    189. Hemorrhage-induced secretion of CORTICOTROPIN –RELEASING FACTOR -like immunoreactivity into the rat hypophysial portal circulation and its inhibition by glucocorticoids
    190. Effects of CORTICOTROPIN –RELEASING FACTOR , CORTICOTROPIN and cortisol on gastrointestinal motility in dogs
    191. Effect of angiotensin II on ACTH release in vivo: role of CORTICOTROPIN –RELEASING FACTOR
    192. Endogenous opioid peptides modulate the effect of CORTICOTROPIN –RELEASING FACTOR on gonadotropin release in the primate
    193. Quantification of Morphological Changes in Pituitary Corticotropes Produced by in Vivo CORTICOTROPIN –RELEASING FACTOR Stimulation and Adrenalectomy
    194. Extrapituitary effects of CORTICOTROPIN –RELEASING FACTOR .
    195. Characterization of CORTICOTROPIN ‐RELEASING FACTOR receptor‐mediated adenylate cyclase activity in the rat central nervous system
    196. Ontogeny of expression of the CORTICOTROPIN –RELEASING FACTOR gene in the hypothalamic paraventricular nucleus and of the proopiomelanocortin gene in rat pituitary
    197. Brain and pituitary receptors for CORTICOTROPIN RELEASING FACTOR : localization and differential regulation after adrenalectomy
    198. Effects of CORTICOTROPIN RELEASING FACTOR on genetically obese (fatty) rats
    199. Brain IL-1-induced immunosuppression occurs through activation of both pituitary-adrenal axis and sympathetic nervous system by CORTICOTROPIN –RELEASING FACTOR
    200. CORTICOTROPIN –RELEASING FACTOR receptor antagonist: effects on the autonomic nervous system and cardiovascular function
    201. CORTICOTROPIN –RELEASING FACTOR immunoreactivity in human gastrointestinal tract
    202. Effects of CORTICOTROPIN RELEASING FACTOR and sauvagine on social behavior of isolated mice
    203. Immunoreactive CORTICOTROPIN –RELEASING FACTOR and CORTICOTROPIN during pregnancy, labor and puerperium
    204. Desensitization of CORTICOTROPIN –RELEASING FACTOR receptors
    205. The ontogeny of brain receptors for CORTICOTROPIN –RELEASING FACTOR and the development of their functional association with adenylate cyclase
    206. CORTICOTROPIN –RELEASING FACTOR elicits naloxone sensitive stress-like alterations in exploratory behavior in mice
    207. Clinical studies with CORTICOTROPIN RELEASING FACTOR : implications for the diagnosis and pathophysiology of depression, Cushing’s disease, and adrenal insufficiency
    208. Central CORTICOTROPIN –RELEASING FACTOR mediates the suppressive effect of stress on natural killer cytotoxicity
    209. Central administration of CORTICOTROPIN RELEASING FACTOR alters rat pup isolation calls
    210. Release of CORTICOTROPIN –RELEASING FACTOR from Rat Brain Regions in Vitro
    211. A novel mechanism of action of CORTICOTROPIN RELEASING FACTOR in rat Leydig cells.
    212. Central CORTICOTROPIN –RELEASING FACTOR suppresses natural killer cytotoxicity
    213. Binding of [125I] CORTICOTROPIN RELEASING FACTOR to blood immunocytes and its reduction in Alzheimer’s disease
    214. Involvement of CORTICOTROPIN –RELEASING FACTOR and somatostatin in stress-induced inhibition of growth hormone secretion in the rat
    215. Stimulation of rat B‐lymphocyte proliferation by CORTICOTROPIN ‐RELEASING FACTOR
    216. Evidence for the involvement of endogenous opioids in the inhibition of luteinizing hormone by CORTICOTROPIN –RELEASING FACTOR
    217. CORTICOTROPIN –RELEASING FACTOR -like immunoreactivity in senile dementia of the Alzheimer type: reduced cortical and striatal concentrations
    218. Neuromodulatory effects of CORTICOTROPIN RELEASING FACTOR on cerebellar Purkinje cells: an in vivo study in the cat
    219. Thermogenic effects of the antiglucocorticoid RU-486 in the rat: involvement of CORTICOTROPIN –RELEASING FACTOR and sympathetic activation of brown adipose tissue
    220. CORTICOTROPIN –RELEASING FACTOR synapses within the paraventricular nucleus of the hypothalamus
    221. Cholecystokinin‐, galanin‐, and CORTICOTROPIN ‐RELEASING FACTOR ‐like immunoreactive projections from the nucleus of the solitary tract to the parabrachial nucleus in the …
    222. Sympatho-adrenal medullary functions in response to intracerebroventricularly injected CORTICOTROPIN –RELEASING FACTOR in anesthetized rats
    223. The paraventriculo-infundibular CORTICOTROPIN RELEASING FACTOR (CRF) pathway as revealed by immunocytochemistry in long-term hypophysectomized or …
    224. Differential regulation of brain and pituitary CORTICOTROPIN –RELEASING FACTOR receptors by corticosterone
    225. Increase of CORTICOTROPIN –RELEASING FACTOR staining in rat paraventricular nucleus neurones by depletion of hypothalamic adrenaline
    226. Comparative immunocytochemical localization of CORTICOTROPIN RELEASING FACTOR (CRF-41) and neurohypophysial peptides in the brain of Brattleboro and Long-Evans …
    227. Receptor-mediated actions of CORTICOTROPIN –RELEASING FACTOR in pituitary gland and nervous system
    228. The CORTICOTROPIN –RELEASING FACTOR release in rat hypophysial portal blood is mediated by brain catecholamines
    229. Evidence for the presence of tumor peptides with CORTICOTROPIN –RELEASING –FACTOR -like activity in the ectopic ACTH syndrome
    230. CORTICOTROPIN –RELEASING FACTOR test in normal subjects and patients with hypothalamic-pituitary-adrenal disorders
    231. Induction of β-endorphin secretion by lymphocytes after subcutaneous administration of CORTICOTROPIN –RELEASING FACTOR
    232. Inhibition of immunoreactive CORTICOTROPIN –RELEASING FACTOR secretion into the hypophysial-portal circulation by delayed glucocorticoid feedback
    233. Lactation inhibits stress-mediated secretion of corticosterone and oxytocin and hypothalamic accumulation of CORTICOTROPIN –RELEASING FACTOR and enkephalin messenger …
    234. Central CORTICOTROPIN –RELEASING FACTOR administration prevents the excessive body weight gain of genetically obese (fa/fa) rats
    235. Immunohistochemical study of neurons containing CORTICOTROPIN ‐RELEASING FACTOR in Alzheimer’s disease
    236. Cloning and sequence analysis of cDNA for CORTICOTROPIN –RELEASING FACTOR precursor from the teleost fish Catostomus commersoni
    237. CORTICOTROPIN –RELEASING FACTOR in humans
    238. Behavioral effects of ovine CORTICOTROPIN –RELEASING FACTOR administered to rhesus monkeys.
    239. Effects of adrenalectomy and dexamethasone administration on the level of prepro-CORTICOTROPIN –RELEASING FACTOR messenger ribonucleic acid (mRNA) in the …
    240. CORTICOTROPIN –RELEASING FACTOR and parturition: plasma and amniotic fluid levels and placental binding sites.
    241. Gonadal regulation of CORTICOTROPIN –RELEASING FACTOR immunoreactivity in hypothalamus
    242. ACTH, cortisol, and corticosterone output after ovine CORTICOTROPIN –RELEASING FACTOR challenge during depression and after recovery
    243. New hypothalamic hormone, CORTICOTROPIN –RELEASING FACTOR , specifically stimulates the release of adrenocorticotropic hormone and cortisol in man
    244. Ectopic ACTH syndrome caused by a bronchial carcinoid tumor responsive to dexamethasone, metyrapone, and CORTICOTROPIN –RELEASING FACTOR
    245. Chronic cocaine administration alters CORTICOTROPIN –RELEASING FACTOR receptors in the rat brain
    246. Presence of immunoreactive CORTICOTROPIN –RELEASING FACTOR in rat testis
    247. Modulation of basal and CORTICOTROPIN –RELEASING FACTOR -stimulated proopiomelanocortin gene expression by vasopressin in rat anterior pituitary
    248. Hypophysial-portal plasma levels, median eminence content, and immunohistochemical staining of CORTICOTROPIN –RELEASING FACTOR , arginine vasopressin, and oxytocin …
    249. Reductions in CORTICOTROPIN RELEASING FACTOR ‐like immunoreactivity in cerebral cortex in Alzheimer’s disease, Parkinson’s disease, and progressive supranuclear palsy
    250. Effect of the long-term administration of CORTICOTROPIN –RELEASING FACTOR on the pituitary-adrenal and pituitary-gonadal axis in the male rat.
    251. Mechanism of action of interleukin-1β in increasing CORTICOTROPIN –RELEASING FACTOR and adrenoCORTICOTROPIN hormone release from cultured human placental cells
    252. CORTICOTROPIN –RELEASING FACTOR stimulates the release of adrenoCORTICOTROPIN from domestic fowl pituitary cells
    253. Stress-induced secretion of adrenoCORTICOTROPIN in rats is inhibited by administration of antisera to ovine CORTICOTROPIN –RELEASING FACTOR and vasopressin
    254. CORTICOTROPIN –RELEASING FACTOR (CRF) immunoreactivity in the dorsolateral pontine tegmentum: further studies on the micturition reflex system
    255. Ovine CORTICOTROPIN –RELEASING FACTOR administration in normal men
    256. Arginine vasopressin is a much more potent stimulus to ACTH release from ovine anterior pituitary cells than ovine CORTICOTROPIN –RELEASING FACTOR
    257. CORTICOTROPIN ‐RELEASING FACTOR immunoreactivity in monkey neocortex: An immunohistochemical analysis
    258. CORTICOTROPIN ‐RELEASING FACTOR mRNA in the hypothalamus is affected differently by drinking saline and by dehydration
    259. Alcohol reverses the proconflict effect of CORTICOTROPIN –RELEASING FACTOR
    260. The role of IL-1 in the CORTICOTROPIN –RELEASING FACTOR and arginine-vasopressin-induced secretion of immunoreactive beta-endorphin by human peripheral blood …
    261. CORTICOTROPIN –RELEASING FACTOR inhibits neurogenic plasma extravasation in the rat paw.
    262. [38] CORTICOTROPIN –RELEASING FACTOR receptors in the pituitary gland and central nervous system: Methods and overview
    263. CORTICOTROPIN –RELEASING FACTOR (CRF) acts centrally to inhibit growth hormone secretion in the rat
    264. CORTICOTROPIN –RELEASING FACTOR in the olivocerebellar tract of rats: demonstration by light-and electron-microscopic immunohistochemistry and in situ hybridization …
    265. Effect of synthetic ovine CORTICOTROPIN –RELEASING FACTOR : prolonged duration of action and biphasic response of plasma adrenoCORTICOTROPIN and cortisol
    266. Demonstration of distinct CORTICOTROPIN RELEASING FACTOR —containing neuron populations in the bed nucleus of the stria terminalis. A light and electron microscopic …
    267. Different epileptogenic activities of murine and ovine CORTICOTROPIN –RELEASING FACTOR
    268. CORTICOTROPIN RELEASING FACTOR : a new tool for the differential diagnosis of Cushing’s syndrome
    269. CORTICOTROPIN –RELEASING FACTOR receptors in mouse spleen: identification of receptor-bearing cells as resident macrophages
    270. The involvement of central noradrenergic systems and CORTICOTROPIN –RELEASING FACTOR in defensive-withdrawal behavior in rats.
    271. CORTICOTROPIN –RELEASING FACTOR (CRF)-like immunoreactivity in the vertebrate endocrine pancreas
    272. In vitro study of immunoreactive CORTICOTROPIN –RELEASING FACTOR release from the rat hypothalamus
    273. CORTICOTROPIN –RELEASING FACTOR receptors in rat pituitary gland: autoradiographic localization
    274. Central autonomic modulation of cardiac baroreflex by CORTICOTROPIN –RELEASING FACTOR
    275. Insulin-induced hypoglycemia stimulates CORTICOTROPIN –RELEASING FACTOR and arginine vasopressin secretion into hypophysial portal blood of conscious, unrestrained …
    276. Glucocorticoid implants around the hypothalamic paraventricular nucleus prevent the increase of CORTICOTROPIN –RELEASING FACTOR and arginine vasopressin …
    277. CORTICOTROPIN –RELEASING FACTOR , sauvagine, and urotensin I: effects on blood flow
    278. Single or repeated mild stress increases synthesis and release of hypothalamic CORTICOTROPIN –RELEASING FACTOR
    279. Monoamine metabolites, CORTICOTROPIN RELEASING FACTOR and somatostatin as CSF markers in depressed patients
    280. CORTICOTROPIN RELEASING FACTOR distribution in normal and Brattleboro rat brain, and effect of deafferentation, hypophysectomy and steroid treatment in normal animals
    281. CORTICOTROPIN –RELEASING FACTOR binding to the anterior pituitary receptor is modulated by divalent cations and guanyl nucleotides
    282. Combined administration of human CORTICOTROPIN –RELEASING FACTOR and lysine vasopressin induces cortisol escape from dexamethasone suppression in healthy subjects
    283. The status of the CORTICOTROPIN RELEASING FACTOR (CRF)
    284. CORTICOTROPIN –RELEASING FACTOR stimulates secretion of melanocyte-stimulating hormone from the rat pituitary
    285. Evidence for the involvement of CORTICOTROPIN –RELEASING FACTOR in the gastrointestinal disturbances induced by acoustic and cold stress in mice
    286. Ultrastructural localization of glucocorticoid receptor (GR) in hypothalamic paraventricular neurons synthesizing CORTICOTROPIN RELEASING FACTOR (CRF)
    287. Isolation and amino acid sequence of CORTICOTROPIN –RELEASING FACTOR from pig hypothalami
    288. Regulation of CORTICOTROPIN –RELEASING FACTOR (CRF) receptors in the rat pituitary gland: effects of adrenalectomy on CRF receptors and corticotroph responses
    289. Inhibitory effect of adrenoCORTICOTROPIN on CORTICOTROPIN –RELEASING FACTOR release from rat hypothalamus in vitro
    290. Starvation-induced changes in rat brain CORTICOTROPIN –RELEASING FACTOR (CRF) and putuitary-adrenocortical response
    291. Modulation of central nervous system actions of CORTICOTROPIN –RELEASING FACTOR by dynorphin-related peptides
    292. Modulation of lordosis behaviour in the female rat by CORTICOTROPIN RELEASING FACTOR , β-endorphin and gonadotropin RELEASING hormone in the mesencephalic central …
    293. Angiotensin II and ACTH release: site of action and potency relative to CORTICOTROPIN RELEASING FACTOR and vasopressin
    294. Rat preprocarboxypeptidase H: Cloning, characterization, and sequence of the cDNA and regulation of the mRNA by CORTICOTROPIN –RELEASING FACTOR
    295. … -and alpha-2-adrenergic-binding sites to regions of the paraventricular nucleus of the hypothalamus containing CORTICOTROPIN –RELEASING FACTOR and vasopressin neurons
    296. CORTICOTROPIN RELEASING FACTOR administered into the ventricular CSF stimulates the pituitary-adrenal axis
    297. A new cytotoxin specific for the target cells of CORTICOTROPIN –RELEASING FACTOR
    298. Evidence for a role of endogenous CORTICOTROPIN –RELEASING FACTOR in cold, ether, immobilization, and traumatic stress
    299. Demonstration of glucocorticoid receptor‐like immunoreactivity in glucocorticoid‐sensitive vasopressin and CORTICOTROPIN ‐RELEASING FACTOR neurons in the hypothalamic …
    300. Surface properties of an amphiphilic peptide hormone and of its analog: CORTICOTROPIN –RELEASING FACTOR and sauvagine
    301. Purification of hypothalamic CORTICOTROPIN RELEASING FACTOR .
    302. Neuropeptide Y administration acutely increases hypothalamic CORTICOTROPIN –RELEASING FACTOR immunoreactivity: lack of effect in other rat brain regions
    303. Iontophoretic mapping of CORTICOTROPIN –RELEASING FACTOR (CRF) sensitive neurons in the rat forebrain
    304. Acetylcholine and Norepinephrine Stimulate the Release of CORTICOTROPIN –RELEASING FACTOR -41 from the Rat Hypothalamus in Vitro
    305. Inhibition of gastric acid secretion in rats and in dogs by CORTICOTROPIN –RELEASING FACTOR
    306. CORTICOTROPIN –RELEASING FACTOR : central action to influence gastric secretion.
    307. ACTH and multisteroid responses to CORTICOTROPIN –RELEASING FACTOR in depressive illness: relationship to multisteroid responses after ACTH stimulation and …
    308. Characterization and biological activity of a rat monoclonal antibody to rat/human CORTICOTROPIN –RELEASING FACTOR
    309. Role of cholecystokinin in CORTICOTROPIN release: coexistence with vasopressin and CORTICOTROPIN –RELEASING FACTOR in cells of the rat hypothalamic paraventricular nucleus
    310. Inhibition of CORTICOTROPIN release during hypothermia: the role of CORTICOTROPIN –RELEASING FACTOR , vasopressin, and oxytocin
    311. CSF CORTICOTROPIN –RELEASING FACTOR (CRF) in Alzheimer’s disease: its relationship to severity of dementia and monoamine metabolites
    312. Characterization of immunoreactive CORTICOTROPIN and CORTICOTROPIN –RELEASING FACTOR in human adrenal and ovarian tumours
    313. Localization of urotensin I-and CORTICOTROPIN –RELEASING FACTOR -like immunoreactivity in the central nervous system of Catostomus commersoni
    314. Plasma adrenoCORTICOTROPIN , cortisol, and aldosterone responses to CORTICOTROPIN –RELEASING FACTOR : modulatory effect of basal cortisol levels
    315. Ethanol Exposure Decreases Pituitary CORTICOTROPIN –RELEASING FACTOR Binding, Adenylate Cyclase Activity, Proopiomelanocortin Biosynthesis, and Plasma β …
    316. CORTICOTROPIN RELEASING FACTOR -like immunoreactivity in sensory ganglia and capsaicin sensitive neurons of the rat central nervous system: colocalization with other …
    317. CORTICOTROPIN –RELEASING FACTOR in the dog adrenal medulla is secreted in response to hemorrhage
    318. Effect of paraventricular lesions on CORTICOTROPIN –RELEASING FACTOR (CRF)-like immunoreactivity in the stalk-median eminence: studies on the adrenoCORTICOTROPIN …
    319. Involvement of CORTICOTROPIN –RELEASING FACTOR in restraint stress-induced anorexia and reversion of the anorexia by somatostatin in the rat
    320. Coexistence of peptides (CORTICOTROPIN RELEASING FACTOR /neurotensin and substance P/somatostatin) in the bed nucleus of the stria terminalis and central amygdaloid …
    321. Influence of the frequency of ovine CORTICOTROPIN –RELEASING FACTOR administration on adrenoCORTICOTROPIN and corticosterone secretion in the rat
    322. Adrenal modulation of the inhibitory effect of CORTICOTROPIN RELEASING FACTOR on feeding
    323. In vitro potentiation of the activity of synthetic ovine CORTICOTROPIN –RELEASING FACTOR by arginine vasopressin
    324. Regulation of CORTICOTROPIN –RELEASING FACTOR secretion in vitro by glucose
    325. Distribution and coexistence of CORTICOTROPIN –RELEASING FACTOR -, neurotensin-, enkephalin-, cholecystokinin-, galanin-and vasoactive intestinal polypeptide/peptide …
    326. Structural homology of CORTICOTROPIN –RELEASING FACTOR , sauvagine, and urotensin I: circular dichroism and prediction studies
    327. Stress and CORTICOTROPIN –RELEASING FACTOR potentiate center region activity of mice in an open field
    328. Vasopressin stimulation of adrenoCORTICOTROPIN hormone (ACTH) in humans. In vivo bioassay of CORTICOTROPIN –RELEASING FACTOR (CRF) which provides evidence for CRF …
    329. Effects of intracerebroventricular administration of growth hormone-RELEASING FACTOR and CORTICOTROPIN –RELEASING FACTOR on somatostatin secretion into rat hypophysial …
    330. Localization of CORTICOTROPIN –RELEASING FACTOR -containing neurons in the brain of the domestic fowl
    331. Distribution of CORTICOTROPIN ‐RELEASING FACTOR in the cerebellum and precerebellar nuclei of the cat
    332. Structural characterization and localization of CORTICOTROPIN –RELEASING FACTOR in testis
    333. Dementia of the Alzheimer type and hypothalamus‐pituitary‐adrenocortical axis: changes in cerebrospinal fluid CORTICOTROPIN RELEASING FACTOR and plasma cortisol …
    334. Ovine CORTICOTROPIN –RELEASING FACTOR stimulates somatostatin secretion from cultured brain cells
    335. Regional hemodynamic responses to central administration of CORTICOTROPIN –RELEASING FACTOR (CRF)
    336. Distribution of CORTICOTROPIN ‐RELEASING ‐FACTOR ‐like immunoreactivity in brainstem of two monkey species (Saimiri sciureus and Macaca fascicularis): An …
    337. Glucocorticoids Inhibit CORTICOTROPIN –RELEASING FACTOR -Induced Production of Adenosine 3′,5′-Monophosphate in Cultured Anterior Pituitary Cells
    338. Presence of immunoreactive CORTICOTROPIN –RELEASING FACTOR in human corebrospinal fluid
    339. Isolation and characterization of caprine CORTICOTROPIN –RELEASING FACTOR
    340. Evidence for local CORTICOTROPIN RELEASING FACTOR (CRF)-immunoreactive neuronal circuits in the paraventricular nucleus of the rat hypothalamus
    341. … (PHI-27)/CORTICOTROPIN –RELEASING FACTOR /enkephalin immunoreactive hypothalamic neuron: possible morphological basis for integrated control of prolactin, CORTICOTROPIN …
    342. β-Lipotropin—β-Endorphin Response to Low-Dose Ovine CORTICOTROPIN RELEASING FACTOR in Endogenous Depression: Preliminary Studies
    343. CORTICOTROPIN –RELEASING FACTOR (CRF) increases paradoxical sleep (PS) rebound in PS-deprived rats
    344. CORTICOTROPIN RELEASING FACTOR (CRF) immunoreactivity in hypothalamic and extrahypothalamic nuclei of sheep brain
    345. Influence of the central nucleus of the amygdala on the content of CORTICOTROPIN –RELEASING FACTOR in the median eminence
    346. Distribution of CORTICOTROPIN RELEASING FACTOR -like immunoreactivity in the rat brain by immunohistochemistry and radioimmunoassay: comparison and characterization of …
    347. Immunocytochemical localization of CORTICOTROPIN –RELEASING FACTOR -like immunoreactivity in the human hypothalamus
    348. Ontogeny of CORTICOTROPIN –RELEASING FACTOR and arginine vasopressein in the rat
    349. Role of CORTICOTROPIN –RELEASING FACTOR in mediating the expression of defensive behavior.
    350. Neuropeptide Y-induced effects on hypothalamic CORTICOTROPIN –RELEASING FACTOR content and release are dependent on noradrenergic/adrenergic neurotransmission
    351. Abnormal ACTH and cortisol responses to ovine CORTICOTROPIN RELEASING FACTOR in patients with primary affective disorder
    352. Onset of glucocorticoid responsiveness of anterior pituitary corticotrophs during development is scheduled by CORTICOTROPIN –RELEASING FACTOR
    353. Stimulation of adrenoCORTICOTROPIN /β-endorphin release by synthetic ovine CORTICOTROPIN –RELEASING FACTOR in vitro
    354. AdrenoCORTICOTROPIN , β-lipotropin, β-endorphin, and CORTICOTROPIN –RELEASING FACTOR -like activity in an adrenoCORTICOTROPIN -producing nephroblastoma
    355. The CORTICOTROPIN RELEASING FACTOR (CRF) neurosecretory system in intact, adrenalectomized, and adrenalectomized-dexamethasone treated rats
    356. The hippocampus and amygdala mediate the locomotor stimulating effects of CORTICOTROPIN –RELEASING FACTOR in mice
    357. CORTICOTROPIN RELEASING FACTOR stimulates adrenoCORTICOTROPIN and β-endorphin release from AtT-20 mouse pituitary tumor cells
    358. Co-localization of the immunoreactivities of CORTICOTROPIN –RELEASING FACTOR and arginine vasotocin in the brain and pituitary system of the teleost Catostomus …
    359. Coexistence of CORTICOTROPIN ‐RELEASING FACTOR and enkephalin in the paraventricular nucleus of the rat
    360. Immunoreactive dynorphin-(1-8) and CORTICOTROPIN –RELEASING FACTOR in subpopulation of hypothalamic neurons
    361. Glutamic acid decarboxylase-and γ-aminobutyric acid-like immunoreactivities in CORTICOTROPIN –RELEASING FACTOR -containing parvocellular neurons of the hypothalamic …
    362. CORTICOTROPIN –RELEASING FACTOR (CRF)-like immunoreactivity in the adrenal medulla
    363. Isolation and characterization of the bovine hypothalamic CORTICOTROPIN –RELEASING FACTOR
    364. Effects of intraventricular infusion of CORTICOTROPIN –RELEASING FACTOR on VMH-lesioned obese rats
    365. Selective facilitation of putative CORTICOTROPIN –RELEASING FACTOR -secreting neurones by interleukin-1
    366. CORTICOTROPIN RELEASING FACTOR increases proopiomelanocortin messenger RNA in mouse anterior pituitary tumor cells.
    367. CORTICOTROPIN RELEASING FACTOR (CRF) and age-related differences in behavior of mice
    368. Induction of fos-Like Immunoreactivity in Hypothalamic CORTICOTROPIN –RELEASING FACTOR Neurons after Adrenalectomy in the Rat
    369. Insulin-induced hypoglycemia increases CORTICOTROPIN –RELEASING FACTOR messenger ribonucleic acid levels in rat hypothalamus
    370. Heterogeneity between brain and pituitary CORTICOTROPIN –RELEASING FACTOR receptors is due to differential glycosylation
    371. CORTICOTROPIN –RELEASING FACTOR receptors in mouse spleen: identification, autoradiographic localization, and regulation by divalent cations and guanine nucleotides
    372. Alcohol exposure in utero results in diminished T‐cell function and alterations in brain CORTICOTROPIN ‐RELEASING FACTOR and ACTH content
    373. Corticosterone-induced changes in hypothalamic CORTICOTROPIN –RELEASING FACTOR (CRF) content after stress
    374. Hypoglycemia enhances turnover of CORTICOTROPIN –RELEASING FACTOR and of vasopressin in the zona externa of the rat median eminence
    375. Immunohistochemical localization and radioimmunoassay of CORTICOTROPIN –RELEASING FACTOR in the forebrain and hypophysis of the frog Rana ridibunda
    376. Release from inflamed tissue of a substance with properties similar to CORTICOTROPIN –RELEASING FACTOR
    377. Nucleotide sequence of the gene coding for ovine CORTICOTROPIN –RELEASING FACTOR and regulation of its mRNA levels by glucocorticoids
    378. Stress mediated changes in hypothalamic CORTICOTROPIN RELEASING FACTOR -like immunoreactivity
    379. CORTICOTROPIN –RELEASING FACTOR in cerebellar afferent systems: a combined immunohistochemistry and retrograde transport study
    380. CORTICOTROPIN RELEASING FACTOR and amphetamine exaggerate partial agonist properties of benzodiazepine antagonist Ro 15-1788 in the conflict test
    381. Hypercorticosteronuria and diminished pituitary responsiveness to CORTICOTROPIN –RELEASING FACTOR in obese Zucker rats
    382. Intrahypothalamic CORTICOTROPIN –RELEASING FACTOR elevates gastric bicarbonate and inhibits stress ulcers in rats
    383. Suppression by glucocorticoid of the immunoreactivity of CORTICOTROPIN –RELEASING FACTOR and vasopressin in the paraventricular nucleus of rat hypothalamus
    384. Properties of rat anterior pituitary vasopressin receptors: relation to adenylate cyclase and the effect of CORTICOTROPIN –RELEASING FACTOR
    385. CORTICOTROPIN –RELEASING FACTOR inhibits gastric emptying in dogs
    386. CORTICOTROPIN –RELEASING FACTOR and angiotensin II: comparison of CNS actions to influence neuroendocrine and cardiovascular function
    387. Behavioral effects of CORTICOTROPIN –RELEASING FACTOR
    388. Central modulation of immunoreactive CORTICOTROPIN –RELEASING FACTOR secretion by arginine vasopressin
    389. Secretion of CORTICOTROPIN RELEASING FACTOR (CRF) and vasopressin (AVP) into the hypophysial portal blood of conscious, unrestrained rams
    390. Regulation of duodenal bicarbonate secretion during stress by CORTICOTROPIN –RELEASING FACTOR and beta-endorphin
    391. Radioautographic study of binding and internalization of CORTICOTROPIN –RELEASING FACTOR by rat anterior pituitary corticotrophs
    392. Effects of serotonin, cyproheptadine and reserpine on CORTICOTROPIN –RELEASING FACTOR release from the rat hypothalamus in vitro
    393. Evidence for the involvement of CORTICOTROPIN –RELEASING FACTOR in the inhibition of gonadotropin release induced by hyperprolactinemia
    394. Effects of intravenous and intraventricular injection of antisera directed against CORTICOTROPIN –RELEASING FACTOR on the secretion of anterior pituitary hormones
    395. Assays for CORTICOTROPIN –RELEASING FACTOR (CRF) using rats treated with morphine, chlorpromazine, dexamethasone and nembutal
    396. Cardiovascular responses to exercise in the rat: role of CORTICOTROPIN –RELEASING FACTOR
    397. CORTICOTROPIN –RELEASING FACTOR receptors in human pituitary gland: autoradiographic localization
    398. Effects of opioid peptides on immunoreactive CORTICOTROPIN –RELEASING FACTOR release from the rat hypothalamus in vitro
    399. Stress-induced alterations in neurotensin, somatostatin and CORTICOTROPIN –RELEASING FACTOR in mesotelencephalic dopamine system regions
    400. Clinical studies with synthetic ovine CORTICOTROPIN –RELEASING FACTOR .
    401. CORTICOTROPIN RELEASING FACTOR (CRF): immunocytochemical localization and radioimmunoassay (RIA)
    402. Immunocytochemical localization of CORTICOTROPIN RELEASING FACTOR (CRF)-like immunoreactivity in the thalamus of the rat
    403. Pituitary and adrenocortical responses to CORTICOTROPIN –RELEASING FACTOR in pigs.
    404. Immunoelectron microscopic localization of CORTICOTROPIN –RELEASING FACTOR in the rat hypothalamus
    405. Effect of CORTICOTROPIN –RELEASING FACTOR , Dexamethasone and Actinomycin D on the Release of ACTH from Rat Pituitaries in Vivo and in Vitro
    406. Vasopressin potentiates cyclic AMP accumulation and ACTH release induced by CORTICOTROPIN –RELEASING FACTOR (CRF) in rat anterior pituitary cells in culture
    407. The hormonal actions of CORTICOTROPIN –RELEASING FACTOR in sheep: effect of intravenous and intracerebroventricular injection
    408. Handling in infancy: increased levels of the hypothalamic CORTICOTROPIN RELEASING FACTOR (CRF) following exposure to a novel situation
    409. Inhibition of rat CORTICOTROPIN –RELEASING FACTOR and adrenoCORTICOTROPIN secretion by an osmotic stimulus
    410. Separate neural substrates of the locomotor-activating properties of amphetamine, heroin, caffeine and CORTICOTROPIN RELEASING FACTOR (CRF) in the rat
    411. Diurnal rhythm of plasma immunoreactive CORTICOTROPIN –RELEASING FACTOR in normal subjects
    412. Coexistence of CORTICOTROPIN –RELEASING FACTOR -like immunoreactivity and vasotocin in perikarya of the preoptic nucleus in the eel
    413. CORTICOTROPIN –RELEASING FACTOR -induced adrenoCORTICOTROPIN hormone release and synthesis is blocked by incorporation of the inhibitor of cyclic AMP-dependent protein …
    414. CORTICOTROPIN –RELEASING FACTOR . Mechanisms to inhibit gastric acid secretion in conscious dogs.
    415. Additive effects of epinephrine and CORTICOTROPIN –RELEASING FACTOR (CRF) on adrenoCORTICOTROPIN release in rat anterior pituitary cells
    416. Brain CORTICOTROPIN –RELEASING FACTOR acts as inhibitor of stress-induced gastric erosion in rats
    417. CORTICOTROPIN –RELEASING FACTOR -like activity in ACTH producing tumors
    418. Secretion of CORTICOTROPIN –RELEASING FACTOR from cultured rat hypothalamic cells: effects of catecholamines
    419. Ultrastructural characteristics of immunolabelled, CORTICOTROPIN RELEASING FACTOR (CRF)-synthesizing neurons in the rat brain
    420. CORTICOTROPIN –RELEASING FACTOR is contained within perikarya and nerve fibres of rat duodenum
    421. Widespread expression of CORTICOTROPIN –RELEASING FACTOR messenger RNA and immunoreactivity in the rat olFACTOR y bulb
    422. CORTICOTROPIN –RELEASING FACTOR receptors: autoradiographic identification.
    423. Effects of CORTICOTROPIN RELEASING FACTOR , desipramine and haloperidol on a DRL schedule of reinforcement
    424. Epidermal growth FACTOR acts as a CORTICOTROPIN –RELEASING FACTOR in chronically catheterized fetal lambs.
    425. CORTICOTROPIN RELEASING FACTOR (CRF): origin and course of afferent pathways to the median eminence (ME) of the rat hypothalamus
    426. CORTICOTROPIN –RELEASING FACTOR as a possible cause of comorbidity in anxiety and depressive disorders.
    427. Involvement of vasopressin in the down-regulation of pituitary CORTICOTROPIN –RELEASING FACTOR receptors after adrenalectomy
    428. Distribution of CORTICOTROPIN –RELEASING FACTOR in ovine brain determined by radioimmunoassay
    429. Glucocorticoids regulate ovine hypophysial portal levels of CORTICOTROPIN –RELEASING FACTOR and arginine vasopressin in a stress-specific manner
    430. Comparative effects of CORTICOTROPIN –RELEASING FACTOR , arginine vasopressin, and related neuropeptides on the secretion of ACTH and α-MSH by frog anterior pituitary …
    431. Inhibition by Dexamethasone of the in Vivo Pituitary Response to CORTICOTROPIN –RELEASING FACTOR (CRF)1
    432. Vasopressin and CORTICOTROPIN ‐RELEASING FACTOR : an axonal pathway to portal capillaries in the zona externa of the median eminence containing vasopressin and its …
    433. Behavioral investigation of the coexistence of substance P, CORTICOTROPIN RELEASING FACTOR , and acetylcholinesterase in lateral dorsal tegmental neurons projecting to the …
    434. Low doses of CORTICOTROPIN –RELEASING FACTOR potentiate amphetamine-induced stereotyped behavior
    435. Predominant release of vasopressin vs. CORTICOTROPIN –RELEASING FACTOR from the isolated median eminence after adrenalectomy
    436. EEG stability following CORTICOTROPIN RELEASING FACTOR in rats
    437. CORTICOTROPIN –RELEASING FACTOR binding to peripheral tissue and activation of the adenylate cyclase-adenosine 3′, 5′-monophosphate system
    438. Active clearance of CORTICOTROPIN –RELEASING FACTOR from the cerebrospinal fluid
    439. CORTICOTROPIN –RELEASING FACTOR (CRF) and interleukin-1 (IL-1) receptors in the brain-pituitary-immune axis.
    440. CORTICOTROPIN ‐RELEASING FACTOR is altered in brains of animals with high preference for ethanol
    441. Immunohistochemical demonstration of the localization of CORTICOTROPIN RELEASING FACTOR -containing neurons in the hypothalamus of mammals including primates
    442. Intrahypothalamic microinfusion of CORTICOTROPIN –RELEASING FACTOR inhibits gastric acid secretion but increases secretion volume in rats
    443. CORTICOTROPIN –RELEASING FACTOR (CRF)-like immunoreactivity in the gastro-entero-pancreatic endocrine system
    444. Associated endocrine, physiological and behavioral changes in rhesus monkeys after intravenous CORTICOTROPIN –RELEASING FACTOR administration
    445. Responsiveness of the hypophyseal-adrenocortical axis to CORTICOTROPIN –RELEASING FACTOR in pituitary-dependent Cushing’s disease
    446. CORTICOTROPIN –RELEASING FACTOR in Humans
    447. Hypothalamic organization of CORTICOTROPIN RELEASING FACTOR (CRF) producing structures
    448. CORTICOTROPIN –RELEASING FACTOR -induced stimulation of immune functions
    449. Immunoreactive CORTICOTROPIN –RELEASING FACTOR in rat plasma
    450. Autonomic and cardiovascular effects of CORTICOTROPIN –RELEASING FACTOR in the spontaneously hypertensive rat
    451. Plasma distribution, disappearance half-time, metabolic clearance rate, and degradation of synthetic ovine CORTICOTROPIN –RELEASING FACTOR in man
    452. Ovine CORTICOTROPIN –RELEASING FACTOR and dexamethasone responses in hyperandrogenic women
    453. CORTICOTROPIN ‐RELEASING FACTOR : isolation and chemical properties
    454. CORTICOTROPIN –RELEASING FACTOR : putative neurotransmitter in the noradrenergic nucleus locus ceruleus.
    455. Antagonistic effect of somatostatin on CORTICOTROPIN –RELEASING FACTOR -induced anorexia in the rat
    456. Binding sites for CORTICOTROPIN RELEASING FACTOR in sensory areas of the rat hindbrain and spinal cord
    457. Optokinetic stimulation increases CORTICOTROPIN –RELEASING FACTOR mRNA in inferior olivary neurons of rabbits
    458. Central modulation of immunoreactive arginine vasopressin and oxytocin secretion into the hypophysial-portal circulation by CORTICOTROPIN –RELEASING FACTOR .
    459. Effects of cyproheptadine, reserpine, and synthetic CORTICOTROPIN –RELEASING FACTOR on pituitary glands from patients with Cushing’s disease
    460. Paradoxical responsiveness of growth hormone to CORTICOTROPIN –RELEASING FACTOR in acromegaly
    461. Central nervous system actions of CORTICOTROPIN –RELEASING FACTOR on cardiovascular function in the absence of locomotor activity
    462. CORTICOTROPIN –RELEASING FACTOR acts centrally to suppress stimulated gastric contractility in the rat
    463. The CORTICOTROPIN –RELEASING FACTOR test in the differential diagnosis of Cushing’s syndrome: a comparison with the lysine-vasopressin test
    464. Further studies on CORTICOTROPIN RELEASING FACTOR (CRF); CORTICOTROPIN RELEASING activity of synthetic peptides
    465. Effects of catecholamine-depleting medullary knife cuts on CORTICOTROPIN –RELEASING FACTOR and vasopressin immunoreactivity in the hypothalamus of normal and steroid …
    466. Involvement of hypothalamic somatostatin in the suppression of growth hormone secretion by central CORTICOTROPIN –RELEASING FACTOR in conscious male rats
    467. CORTICOTROPIN –RELEASING FACTOR desensitization of adrenocorticotropic hormone release is augmented by arginine vasopressin
    468. Effects of CORTICOTROPIN –RELEASING FACTOR (CRF) and opiates on amphibian locomotion
    469. Immunohistochemical identification of neurons containing CORTICOTROPIN –RELEASING FACTOR in the rat hypothalamus
    470. … secretion by dispersed rat anterior pituitary cells in a microperifusion system: effects of ovine CORTICOTROPIN –RELEASING FACTOR and arginine vasopressin
    471. Distribution and characterization of CORTICOTROPIN –RELEASING FACTOR and arginine vasopressin in rat hypothalamic nuclei
    472. Central CORTICOTROPIN RELEASING FACTOR reduces natural cytotoxicity. Time course of action.
    473. Functional CORTICOTROPIN –RELEASING FACTOR receptors in neonatal rat spinal cord
    474. Identification and characterization of a pituitary CORTICOTROPIN –RELEASING FACTOR binding protein by chemical cross-linking.
    475. Chronic ethanol exposure potentiates the locomotor-activating effects of CORTICOTROPIN –RELEASING FACTOR (CRF) in rats
    476. Phorbol 12-myristate 13-acetate and vasopressin potentiate the effect of CORTICOTROPIN –RELEASING FACTOR on cyclic AMP production in rat anterior pituitary cells …
    477. CORTICOTROPIN –RELEASING FACTOR stimulates adenylate cyclase activity in the anterior pituitary gland
    478. CORTICOTROPIN –RELEASING FACTOR concentrations exhibit an apparent diurnal rhythm in hypothalamic and extrahypothalamic brain regions: differential sensitivity to …
    479. Pituitary receptors for CORTICOTROPIN –RELEASING FACTOR : no effect of vasopressin on binding or activation of adenylate cyclase
    480. CORTICOTROPIN –RELEASING FACTOR acts via a third ventricle site to reduce exploratory behavior in rats
    481. CORTICOTROPIN –RELEASING FACTOR (CRF) Induces Desensitization of the Rat Pituitary CRF Receptor Adenylate Cyclase Complex
    482. Cytochemical studies of CORTICOTROPIN –RELEASING FACTOR (CRF) receptors in anterior lobe corticotropes: binding, glucocorticoid regulation, and endocytosis of [biotinyl …
    483. CORTICOTROPIN –RELEASING FACTOR : central nervous system effects on baroreflex control of heart rate
    484. CORTICOTROPIN –RELEASING FACTOR -binding protein is a glycoprotein
    485. Evidence for basal and stress-induced release of CORTICOTROPIN RELEASING FACTOR in the push-pull cannulated median eminence of conscious free-moving rats
    486. Protective actions of CORTICOTROPIN –RELEASING FACTOR on thermal injury to rat pawskin.
    487. CORTICOTROPIN –RELEASING FACTOR inhibits gastric emptying in dogs: studies on its mechanism of action
    488. Distribution of CORTICOTROPIN RELEASING FACTOR (s) activity in neural and extraneural tissues of the rat
    489. CORTICOTROPIN RELEASING FACTOR -like peptides produce selective dilatation of the dog mesenteric circulation
    490. Immediate and delayed alterations of adrenoCORTICOTROPIN and cortisol nyctohemeral profiles after CORTICOTROPIN –RELEASING FACTOR in normal man
    491. … of the cAMP-dependent protein kinases in AtT20 cells. Preferential activation of protein kinase I by CORTICOTROPIN RELEASING FACTOR , isoproterenol, and forskolin.
    492. Brain CORTICOTROPIN RELEASING FACTOR in the spontaneously hypertensive rat.
    493. Inhibition of protein exudation from the trachea by CORTICOTROPIN –RELEASING FACTOR
    494. CORTICOTROPIN –RELEASING FACTOR stimulates the release of methionine-enkephalin and dynorphin from the neostriatum and globus pallidus of the rat: in vitro and in vivo …
    495. CORTICOTROPIN –RELEASING FACTOR : a marked circadian rhythm in primate cerebrospinal fluid peaks in the evening and is inversely related to the cortisol circadian rhythm
    496. Secretion of ACTH by isolated anterior pituitary cells: kinetics of stimulation by CORTICOTROPIN –RELEASING FACTOR and of inhibition by corticosterone
    497. The preferential release of beta-endorphin from the anterior pituitary lobe by CORTICOTROPIN RELEASING FACTOR (CRF)
    498. Angiotensin II and adrenoCORTICOTROPIN release: mediation by endogenous CORTICOTROPIN –RELEASING FACTOR
    499. Capsaicin depletes CORTICOTROPIN –RELEASING FACTOR -like immunoreactive neurons in the rat spinal cord and medulla oblongata
    500. CORTICOTROPIN –RELEASING FACTOR differentially regulates anterior and intermediate pituitary lobe proopiomelanocortin gene transcription, nuclear precursor RNA and …
    501. Dynamic training and circulating levels of CORTICOTROPIN –RELEASING FACTOR , beta-lipotropin and beta-endorphin in rheumatoid arthritis
    502. Improved fixation and cobalt-glucose oxidase-diaminobenzidine intensification for immunohistochemical demonstration of CORTICOTROPIN –RELEASING FACTOR in rat brain.
    503. Effect of CORTICOTROPIN –RELEASING FACTOR on the release and synthesis of prolactin
    504. Cloning and distribution of expression of the rat CORTICOTROPIN –RELEASING FACTOR (CRF) gene
    505. Central administration of CORTICOTROPIN RELEASING FACTOR in the pig: effects on operant feeding, drinking and plasma cortisol
    506. CORTICOTROPIN RELEASING FACTOR ‐containing afferents to the lateral septum of the rat brain
    507. Effects of bilateral adrenalectomy on immunoreactive CORTICOTROPIN –RELEASING FACTOR in the rat median eminence and intermediate-posterior pituitary
    508. Role of central epinephrine on the regulation of CORTICOTROPIN –RELEASING FACTOR and adrenoCORTICOTROPIN secretion
    509. Ovine CORTICOTROPIN –RELEASING FACTOR stimulates the concomitant secretion of CORTICOTROPIN , β-lipotropin, β-endorphin and γ-melanotropin by the bovine adenohypophysis …
    510. CORTICOTROPIN –RELEASING FACTOR secretion increases in rat hypophysial portal blood during insulin-induced hypoglycemia
    511. CORTICOTROPIN –RELEASING FACTOR levels in the peripheral plasma and hypothalamus of the rat vary in parallel with changes in the pituitary-adrenal axis
    512. CORTICOTROPIN RELEASING FACTOR activity of CRF 41 in normal man is potentiated by angiotensin II and vasopressin but not by desmopressin
    513. CORTICOTROPIN –RELEASING FACTOR stimulates phospholipid methylation and CORTICOTROPIN secretion in mouse pituitary tumor cells
    514. Thyrotropin-RELEASING FACTOR -induced adrenoCORTICOTROPIN secretion is mediated by CORTICOTROPIN –RELEASING FACTOR .
    515. High molecular weight peptide with CORTICOTROPIN –RELEASING FACTOR activity from porcine hypothalami
    516. Immunoreactive CORTICOTROPIN –RELEASING FACTOR concentrations in cerebrospinal fluid from patients with hypothalamic-pituitary-adrenal disorders
    517. Edinger-Westphal nucleus: cells that project to spinal cord contain CORTICOTROPIN –RELEASING FACTOR
    518. … in vivo release of opioid peptides and luteinizing hormone-RELEASING hormone from the hypothalamus following blockade of receptors for CORTICOTROPIN –RELEASING FACTOR
    519. CORTICOTROPIN –RELEASING FACTOR (CRF) receptors in intermediate lobe of the pituitary: biochemical characterization and autoradiographic localization
    520. AdrenoCORTICOTROPIN responses to CORTICOTROPIN RELEASING FACTOR and vasopressin in spontaneously hypertensive rats.
    521. Segmental distribution of CORTICOTROPIN –RELEASING FACTOR -like and vasoactive intestinal peptide-like immunoreactivities in presumptive sympathetic preganglionic …
    522. … intestinal polypeptideimmunoreactive neurons in the central nervous system with special reference to their relation to CORTICOTROPIN RELEASING FACTOR -and enkephalin-like …
    523. Sequence analysis of rat hypothalamic CORTICOTROPIN –RELEASING FACTOR with the o-phthalaldehyde strategy
    524. AdrenoCORTICOTROPIN and cortisol responses to ovine CORTICOTROPIN –RELEASING FACTOR in alcohol dependence disorder